NCT06166849

Brief Summary

The study is designed as a split-mouth randomised controlled study. This means within the mouth of one patient one tooth with an initial lesion is treated and coated with the Experimental Remineralization product whereas another comparable tooth with an initial lesion is left untreated. Patients are included upon meeting the inclusion criteria as defined for this clinical trial. In the test group, a remineralization of the incipient carious lesion is expected. The patients are recalled after 1 day (optional), 4 weeks, 4 months and finally after 1 year to evaluate the untreated and treated lesion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 28, 2023

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

December 4, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 12, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2024

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 11, 2025

Completed
1 year until next milestone

Results Posted

Study results publicly available

March 27, 2026

Completed
Last Updated

March 27, 2026

Status Verified

March 1, 2026

Enrollment Period

1.2 years

First QC Date

December 4, 2023

Results QC Date

March 6, 2026

Last Update Submit

March 6, 2026

Conditions

Keywords

white spot lesion

Outcome Measures

Primary Outcomes (2)

  • White Spot Measurement

    Analysis of incipient caries or demineralized enamel by using laser fluorescence technology.

    Baseline to 1 Year

  • ICDAS II Visual Scoring System (Codes)

    Evaluation of the clinical status of the lesions: 0: Sound tooth surface: No evidence of caries after 5 sec air drying 1. First visual change in enamel: Opacity or discoloration (white or brown) is visible at the entrance to the pit or fissure seen after prolonged air drying 2. Distinct visual change in enamel visible when wet, lesion must be visible when dry 3. Localized enamel breakdown (without clinical visual signs of dentinal involvement) seen when wet and after prolonged drying 4. Underlying dark shadow from dentin 5. Distinct cavity with visible dentin 6. Extensive (more than half the surface) distinct cavity with visible dentin

    Baseline to 1 Year

Study Arms (2)

Experimental Fluoride Application

EXPERIMENTAL

Two-step system, consisting of Component A (ammonium fluoride solution) and Component B (calcium fluoride application)

Device: Experimental Fluoride Application

Control Group

NO INTERVENTION

No Treatment

Interventions

The two-step system, consisting of Component A and Component B, will be applied once on the white spot lesions

Experimental Fluoride Application

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least two incipient carious lesions on the buccal or oral surface of a permanent tooth. Neighbouring teeth should not be in two different groups. There is no maximum amount of lesions.
  • Active caries lesion
  • Patient at risk of caries
  • Vital teeth

You may not qualify if:

  • Pregnancy
  • Enamel detachment at the site of investigation
  • Allergies (DoReMin)
  • Chronic diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Iuliu Hatieganu, University of Medicine and Pharmacy

Cluj-Napoca, 400012, Romania

Location

Results Point of Contact

Title
Head of Department Study Management
Organization
Ivoclar Vivadent AG

Study Officials

  • Ada Delean, Prof. Dr.

    Iuliu Hatieganu University of Medicine and Pharmacy

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 4, 2023

First Posted

December 12, 2023

Study Start

March 28, 2023

Primary Completion

May 31, 2024

Study Completion

March 11, 2025

Last Updated

March 27, 2026

Results First Posted

March 27, 2026

Record last verified: 2026-03

Locations